Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
NCT02507141 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2026-03-16
Summary
The purpose of this study is to get images (pictures) of oral lesions, which occur inside the mouth, before the patient's surgery using a special camera. These pictures will be used in our research to evaluate a new technology that uses a laser and takes pictures of the microscopic structure of tissue. The technology is called "reflectance confocal microscopy." We would like to compare what the camera sees to biopsies (pathology) of the same area. We will evaluate the pictures obtained from the patient to determine whether this technology may be useful in the future. We hope this technology can be used as a tool for early diagnosis of oral cancers and for guiding surgery.
Conditions
- Head and Neck Cancer
- Squamous Cell Carcinoma (SCC) of the Oral Cavity
Interventions
- DEVICE
-
Reflectance Confocal Microscopy
Reflectance Confocal Microscopy imaging will be performed during surgery. The imaging procedure is expected to last no more than 15-20 minutes. The approach will be essentially similar to the imaging of skin cancer on patients, which is routinely performed in our Dermatology Service.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Snehal Patel, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-21
- Primary Completion
- 2026-07-31
- Completion
- 2026-07-31
Countries
- United States
Study Locations
More Related Trials
-
Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
NCT05929547 ·Status: NOT_YET_RECRUITING
-
Molecular Imaging-based Dose Escalation in HPV Negative Patients With Locally Advanced SCC of the Oropharynx
NCT02336711 ·Status: UNKNOWN ·Phase: NA
-
Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT02277184 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
NCT01525927 ·Status: TERMINATED ·Phase: PHASE2
-
89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC
NCT05423197 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT05287113 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma
NCT02156180 ·Status: SUSPENDED
-
Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer
NCT00566540 ·Status: TERMINATED ·Phase: PHASE2
-
Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer
NCT00002964 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
NCT04333537 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer
NCT00049140 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx
NCT01140178 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.
NCT01919567 ·Status: UNKNOWN
-
MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck
NCT00427102 ·Status: TERMINATED ·Phase: PHASE1
-
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
NCT01017185 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
NCT00939627 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell Cancer
NCT05296135 ·Status: WITHDRAWN
-
Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas
NCT02279459 ·Status: COMPLETED
-
Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma
NCT03502148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)
NCT02282371 ·Status: COMPLETED ·Phase: PHASE1
-
Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT02277197 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma
NCT01268579 ·Status: COMPLETED ·Phase: NA
-
Impact of Ribociclib on Head and Neck Squamous Cell Cancer
NCT03179956 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097 ·Status: COMPLETED
-
Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions
NCT05327270 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1